Clinical Manifestation and Management of ADPKD in Western Countries.

about

Liver involvement in kidney disease and vice versa.Codonopis bulleynana Forest ex Diels inhibits autophagy and induces apoptosis of colon cancer cells by activating the NF-κB signaling pathway.

P2860

Q39395392-908FC7D4-B8E2-4996-9FF8-B10DEB8EF297 Q47246716-E6BF0DA9-D4DF-4A78-8B00-B6376D9509F1

P2860

Clinical Manifestation and Management of ADPKD in Western Countries.

Item

http://www.wikidata.org/entity/Q39030254

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical Manifestation and Management of ADPKD in Western Countries.

@en

Clinical Manifestation and Management of ADPKD in Western Countries.

@nl

type

Item

label

Clinical Manifestation and Management of ADPKD in Western Countries.

@en

Clinical Manifestation and Management of ADPKD in Western Countries.

@nl

prefLabel

Clinical Manifestation and Management of ADPKD in Western Countries.

@en

Clinical Manifestation and Management of ADPKD in Western Countries.

@nl

P1476

Clinical Manifestation and Management of ADPKD in Western Countries.

@en

P2093

Claudia Sommerer

http://www.w3.org/2001/XMLSchema#string

Martin Zeier

http://www.w3.org/2001/XMLSchema#string

P2860

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

The Treatment of Autosomal Dominant Polycystic Kidney Disease

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Ciliopathies

Vertebrate kidney tubules elongate using a planar cell polarity-dependent, rosette-based mechanism of convergent extension

Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.

Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.

Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group.

Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Estimating prevalence in single-gene kidney diseases progressing to renal failure.

P304

120-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000449394

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27921039

http://www.w3.org/2001/XMLSchema#string

P932

5123001

http://www.w3.org/2001/XMLSchema#string

Clinical Manifestation and Management of ADPKD in Western Countries.

about

P2860

P2860

Clinical Manifestation and Management of ADPKD in Western Countries.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932